Clinical trial

Intestinal Microbiota of Breast Cancer Patients Undergoing Chemotherapy

NCT04138979

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record cyclophosphamide Normalized identity: cyclophosphamideView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Intestinal Microbiota of Breast Cancer Patients Undergoing Chemotherapy

Design: OBSERVATIONAL · Status: UNKNOWN · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2019-09-12

PhaseN/A

Conditions

Microbiotaunresolved

Interventions

cyclophosphamideDRUG · verified · RxNorm: cyclophosphamide

Sponsors & collaborators

First Affiliated Hospital of Harbin Medical Universitylead sponsor

Mapped research locations

HarbinHeilongjiang, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04138979 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.